IBT
UTHR icon

International Biotechnology Trust’s United Therapeutics UTHR Stock Holding History

International Biotechnology Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$7.66M Sell
33,959
-18,800
-36% -$4.33M 2.58% 14
2023
Q2 		$11.6M Buy
52,759
+24,259
+85% +$5.37M 3.55% 9
2023
Q1 		$6.38M Buy
28,500
+13,500
+90% +$3.33M 1.78% 18
2022
Q4 		$4.17M Hold
15,000
– – 1.29% 26
2022
Q3 		$3.14M Buy
15,000
+10,287
+218% +$2.3M 1.01% 30
2022
Q2 		$20K Sell
4,713
-15,287
-76% -$3.11M 0.21% 65
2022
Q1 		$2.94M Buy
+20,000
New +$3.81M 0.66% 36
2021
Q3 		– Sell
-43,300
Closed -$7.77M – 75
2021
Q2 		$7.77M Buy
43,300
+16,700
+63% +$3.18M 2.05% 15
2021
Q1 		$4.45M Buy
+26,600
New +$4.44M 1.18% 23

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return